Presentation is loading. Please wait.

Presentation is loading. Please wait.

Neurocognitive Disorders

Similar presentations


Presentation on theme: "Neurocognitive Disorders"— Presentation transcript:

1 Neurocognitive Disorders
Joe Staggers Alaina Starke Beth Hammond

2 Dementia Not a disease but a group of symptoms
May be reversible or permanent and progressive Caused by brain cell damage

3 Types of Dementia Progressive Dementias Alzheimer’s Disease
Vascular Dementia Lewy Body Dementia Linked Disorders Huntington’s Disease Parkinson’s Disease Traumatic Brain Injury

4 Dementia-like Conditions (reversible)
Infection and immune disorders Metabolic and endocrine disorders Nutrition deficiencies Medication reactions

5 Signs & Symptoms Memory loss, confusion, inability to recognize common things Irritability, personality changes Anxiety, mood changes, nervousness Depression, paranoia, hallucinations

6 Risk Factors >65 years of age Family history Heavy alcohol use
Diabetes mellitus Smoking Obesity

7 Diagnosing NCDs Medical history Mental status testing
Physical and neurological examination Blood tests and brain scans

8 Alzheimer’s Disease Irreversible Incurable Unknown cause

9 Etiology 1) Acetylcholine alterations 2) Plaques and Tangles
3) Head trauma 4) Genetic factors

10 Signs & Symptoms Mental decline, difficulty thinking and understanding, delusion, disorientation, forgetfulness Aggression, agitation, personality changes, wandering Depression, paranoia, hallucinations Jumbled speech, inability to combine muscle movements

11 NCD Meds and Treatments

12 Psychopharmacology Cholinesterase Inhibitors: treat memory, thinking, language, judgement, and other thought processes Tacrine (Cognex) Donepezil (Aricept) Galantmine (Razadyne) Rivastigmine (Exelon) ↑ acetylcholine levels. Eventually ability to improve symptoms declines as brain cell death progresses.

13 Drugs ctd. NMDA Receptor Antagonists: improve memory, attention, reason, language, and the ability to perform simple tasks Mematine (Nemanda) Improve abnormal glutamate activity that may contribute to Alzheimer’s disease. Anxiolytics SSRIs Antipsychotics

14 Non-drug Therapies Focused on recognizing that the person is not just “acting mean or ornery” but is having further symptoms of the disease identifying the cause and how the symptoms may relate to the experience of the person with alzheimer’s changing the environment to resolve challenges and obstacles to comfort, security, and ease of mind

15 Other Considerations Structured programs and activities that provide quality interaction between staff, family members, and patients increase positive outcomes Special training programs for the staff for all levels of education (RN, LPN, CNA) Use of restraints as a last resort and monitor carefully Sensor devises for client safety

16 The End


Download ppt "Neurocognitive Disorders"

Similar presentations


Ads by Google